Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)

Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Mar. 31, 2020

Consolidated Stockholders' Equity Statement [Table Text Block]

													Accumulated
							Additional						Other
	Common Stock						Paid-in			Retained			Comprehensive
	Shares			Amount			Capital			Earnings			Income(Loss)			Total
Balances at June 30, 2019		37,934		$	379		$	316,797		$	931,934		$	(83,521	)	$	1,165,589
Cumulative effect adjustments due to adoption of new accounting standards and other											(879	)					(879	)
Net earnings											14,398						14,398
Other comprehensive income (loss)														(8,106	)		(8,106	)
Common stock issued for exercise of options		94			1			7,854									7,855
Common stock issued for restricted stock awards		50			0			(0	)		(1,926	)					(1,926	)
Cash dividends											(12,169	)					(12,169	)
Stock-based compensation expense								8,267									8,267
Common stock issued to employee stock purchase plan		6			0			1,096									1,096
Employee stock purchase plan expense								99									99
Balances at September 30, 2019		38,084		$	381		$	334,112		$	931,358		$	(91,627	)	$	1,174,224
Net earnings											119,622						119,622
Other comprehensive income (loss)														13,275			13,275
Common stock issued for exercise of options		195			2			18,293									18,295
Common stock issued for restricted stock awards		4			0			(0	)								0
Cash dividends											(12,197	)					(12,197	)
Stock-based compensation expense								10,017									10,017
Common stock issued to employee stock purchase plan
Employee stock purchase plan								112									112
Balance at December 31, 2019		38,283		$	383		$	362,534		$	1,038,783		$	(78,352	)	$	1,323,348
Net earnings											36,432						36,432
Other comprehensive income (loss)														(25,105	)		(25,105	)
Share repurchases		(279	)		(3	)		0			(50,109	)					(50,112	)
Common stock issued for exercise of options		100			1			10,026									10,027
Common stock issued for restricted stock awards		1			0			(0	)		(114	)					(114	)
Cash dividends											(12,279	)					(12,279	)
Stock-based compensation expense								7,745									7,745
Common stock issued to employee stock purchase plan		8			0			1,216									1,216
Employee stock purchase plan								110									110
Balance at March 31, 2020		38,112		$	381		$	381,632		$	1,012,713		$	(103,458	)	$	1,291,268

												Accumulated
							Additional					Other
	Common Stock						Paid-in		Retained			Comprehensive
	Shares			Amount			Capital		Earnings			Income(Loss)			Total
Balances at June 30, 2018		37,608		$	376		$	246,568	$	876,931		$	(44,814	)	$	1,079,061
Cumulative effect adjustments due to adoption of new accounting standards and other										25,276			(24,682	)		594
Net earnings										17,403						17,403
Other comprehensive income (loss)													(1,136	)		(1,136	)
Common stock issued for exercise of options		166			2			15,609								15,611
Common stock issued for restricted stock awards		24			0					(2,405	)					(2,405	)
Cash dividends										(12,066	)					(12,066	)
Stock-based compensation expense								11,327								11,327
Common stock issued to employee stock purchase plan		5			0			842								842
Employee stock purchase plan expense								238								238
Balances at September 30, 2018		37,803		$	378		$	274,584	$	905,139		$	(70,632	)	$	1,109,469
Net earnings										17,556						17,556
Other comprehensive income (loss)													(12,379	)		(12,379	)
Share repurchases		(95	)		(1	)				(15,404	)					(15,404	)
Common stock issued for exercise of options		24						2,408								2,408
Common stock issued for restricted stock awards		3			0											-
Cash dividends										(12,086	)					-
Stock-based compensation expense								6,784								6,784
Common stock issued to employee stock purchase plan		0			0											-
Employee stock purchase plan expense								77								77
Balances at December 31, 2018		37,735		$	377		$	283,854	$	895,205		$	(83,011	)	$	1,096,425
Net earnings										44,654						44,654
Other comprehensive income (loss)													3,378			3,378
Share repurchases																-
Common stock issued for exercise of options		73			1			7,336								7,337
Common stock issued for restricted stock awards		1			0											-
Cash dividends										(12,086	)					(12,086	)
Stock-based compensation expense								5,640								5,640
Common stock issued to employee stock purchase plan		4			0			834								834
Employee stock purchase plan expense								84								84
Balances at March 31, 2019		37,813		$	378		$	297,748	$	927,773		$	(79,633	)	$	1,146,266

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Gains (Losses) on Derivative Instruments			Foreign Currency Translation Adjustments			Total
Balance as of June 30, 2019	$	(9,537	)	$	(73,983	)	$	(83,521	)
Other comprehensive income (loss), net of tax before reclassifications		(6,413	)		(15,138	)		(21,551	)
Reclassification of loss on derivatives to interest expense, net of taxes ⁽³⁾		1,614			-			1,614
Balance as of March 31, 2020⁽¹⁾⁽³⁾	$	(14,336	)	$	(89,121	)	$	(103,458	)

	Gains (Losses) on Derivative Instruments			Foreign Currency Translation Adjustments			Total
Balance as of June 30, 2018⁽²⁾	$	-		$	(69,496	)	$	(69,496	)
Other comprehensive income (loss), net of tax before reclassifications		(5,769	)		(4,368	)		(10,137	)
Balance as of March 31, 2019 ⁽³⁾	$	(5,769	)	$	(73,864	)	$	(79,633	)